Tag Archives: USPTO

Patent Reform Bill Passes Senate – What Will Come To Pass?

Late on March 8th, the Senate almost unanimously passed S. 23, which was only introduced in January. (A copy of the bill is available at the end of this post.) I last commented on the features of this bill in … Continue reading

Posted in Patent Reform Legislation | Tagged , , , , , , , , , | Leave a comment

A Scheme For Maximizing The Benefits Available Under The Patent Prosecution Highway (PPH)

This post is from Mark Horsburgh of Fisher Adams Kelly in Australia. Summary File in Australia first; Request expedited examination (report issues within 3 months); Address objections and obtain acceptance; File in USA and request entry to PPH (faster and … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , , , , , , , | Leave a comment

Teresa Rea Appointed Deputy Director of the USPTO

Teresa Stanek Rea has been appointed Deputy Director of the Patent Office and will report directly to Director Kappos. I don’t remember when I haven’t known Terry, as she has been active in the AIPLA for years. She has been … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , | Leave a comment

ACLU Files Its Brief in Myriad – Argues DNA Is A Blueprint Without a Name

On November 30, 2010, the ACLU filed its brief at the Federal Circuit in AMP et al. v. USPTO and Myriad Genetics, Inc. et al. If you have been reading my posts on this suit, you are by now probably … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , | Leave a comment